Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-256015

Chief Development Officer acquired 1,754 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2026-06-01 Grant or award +877 $70.44 $61,776 3,108 D: show line 1 in the form
Guyer William Chief Development Officer 2026-06-01 Grant or award +877 3,985 D: show line 2 in the form
Loading xslF345X06/ownership.xml…